48
Views
6
CrossRef citations to date
0
Altmetric
CASE REPORT

Intravenous Infusions of Purified Alpha-1 Antitripsyn Effectively Controls Symptoms and Reverts Muscle Biopsy Changes in an MZ Alpha-1 Antitripsyn Deficiency and Fibromyalgia Syndrome Patient

, MD, , PhD, , PhD, , PhD, , PhD, , MD, , PhD, , PhD & , PhD show all
Pages 167-172 | Accepted 08 Apr 2009, Published online: 13 May 2010

REFERENCES

  • Blanco I, Canto H, de Serres FJ, Fernandez-Bustillo E, Rodriguez MC: Alpha 1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha 1-antitrypsin deficiency. J Rheumatol 31(10): 2082–2085, 2004.
  • Blanco I, de Serres FJ, Bustillo EF, Al Kassam D, Arbesú D, Rodríguez C, : Alpha 1-Antitrypsin and fibromyalgia: New data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses (Oxford) 64: 759–769, 2005.
  • Blanco I, Janciauskiene S, Astudillo A, Domínguez F, Bustillo EF, Nita I: Fibromyalgia and alpha-1 antitrypsin, chapter 1. New Research in Fibromyalgia. Nova Science Publisher, New York, 2006.
  • Blanco I, Arbesú D, Al Kassam D, de Serres F, Fernández-Bustillo E, Rodríguez Menéndez C: Alpha 1-antitrypsin polymorphism in fibromyalgia patients from the Asturias Province in Northern Spain: A significantly higher prevalence of the PI*Z deficiency allele in patients than in the general population. J Musculoske Pain 14(3): 5–12, 2006.
  • Russell IJ: Alpha 1-antitrypsin deficiency in the fibromyalgia syndrome. J Musculoske Pain 14(3): 1–3, 2006.
  • Blanco I, De Serres FJ, Janciauskiene S, Arbesú D, Bustillo EF, Cárcaba V, : Estimates of the prevalence and number of fibromyalgia syndrome patients and their alpha-1 antitrypsin phenotypic distribution in ten countries. J Musculoske Pain 15(4): 9–23, 2007.
  • Russell IJ: Pathogenesis of the fibromyalgia syndrome. J Musculoske Pain 15(4): 5–8, 2007.
  • Aldonyte R, Jansson L, Ljungberg O, Larsson S, Janciauskiene S: Polymerized alpha-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of alpha-antitrypsin polymerization. Histopathology 45(6): 587–592, 2004.
  • Janciauskiene S, Stevens T, Blanco I: New insights into the biology of alpha 1-antitrypsin and its role in chronic obstructive pulmonary disease. Curr Respir Med Rev 3: 147–158, 2007.
  • Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, : Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7(7): 821–826, 2001.
  • Vergnolle N: Modulation of visceral pain and inflammation by protease-activated receptors. Br J Pharmacol 141(8): 1264–1274, 2004.
  • Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Blaber M, : Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol Chem 387(6): 817–824, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.